Related Experiment Video
Updated: May 5, 2026

Modified Radical Neck Dissection for Cervical Metastasis
Published on: February 20, 2026
Role of met axis in head and neck cancer
1Department of Dermatology, University of Michigan, Ann Arbor, MI 48109, USA. xuyiru@umich.edu.
Abstract:
Head and neck cancer is the sixth most common type of cancer worldwide. Despite advances in aggressive multidisciplinary treatments, the 5-year survival rate for this dreadful disease is only 50%, mostly due to high rate of recurrence and early involvement of regional lymph nodes and subsequent metastasis. Understanding the molecular mechanisms responsible for invasion and metastasis is one of the most pressing goals in the field of head and neck cancer. Met, also known as hepatocyte growth factor receptor (HGFR), is a member of the receptor protein tyrosine kinase (RPTK) family. There is compelling evidence that Met axis is dysregulated and plays important roles in tumorigenesis, progression, metastasis, angiogenesis, and drug resistance in head and neck cancer. We describe in this review current understanding of Met axis in head and neck cancer biology and development of therapeutic inhibitors targeting Met axis.
Insights
Head and neck cancer survival rates are low due to metastasis. The Met signaling pathway is a key driver of this cancer
Area of Science:
- Oncology
- Molecular Biology
- Cancer Research
Background:
- Head and neck cancer is the sixth most common cancer globally.
- Current 5-year survival rates remain low at 50% due to recurrence and metastasis.
- Understanding molecular mechanisms of invasion and metastasis is critical.
Purpose of the Study:
- To review the current understanding of the Met signaling pathway in head and neck cancer.
- To explore the role of Met in tumorigenesis, progression, metastasis, angiogenesis, and drug resistance.
- To discuss the development of therapeutic inhibitors targeting the Met axis.
Main Methods:
- Literature review of studies on Met signaling in head and neck cancer.
- Analysis of the role of Met (hepatocyte growth factor receptor) in cancer progression.
- Examination of therapeutic strategies targeting the Met axis.
Main Results:
- The Met axis is frequently dysregulated in head and neck cancer.
- Met signaling contributes to tumor growth, invasion, metastasis, and angiogenesis.
- Met pathway dysregulation is implicated in resistance to cancer therapies.
Conclusions:
- The Met axis plays a significant role in head and neck cancer progression and metastasis.
- Targeting the Met axis presents a promising therapeutic strategy for head and neck cancer.
- Further research into Met inhibitors is warranted for improved patient outcomes.
More Related Videos
Related Concept Videos
Metastasis
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
Chemotaxis and Direction of Cell Migration
Arteries of the Head and Neck
The internal carotid arteries supply blood to the anterior portion of the cerebrum. They enter the...

